Every material Form 8-K Electromed, Inc. has filed with the SEC since February 10, 2026, read and summarized by AI: what happened, the key figures, whether it reads positive or negative for shareholders, and how big a deal it is (impact 1-5). Newest first; each brief links to its own page and to the filing on SEC.gov.
Electromed reported record fiscal 2026 results, with net revenues up 15.3% to $73.8 million and net income up to $11.3 million, or $1.30 per diluted share. The company also said CEO and director Jim Cunniff plans to retire on or about April 2, 2027, and the board has begun a search for his successor.
FY 2026 net revenues rose 15.3% to $73.8 million; operating income rose 43.7% to $13.9 million
Q4 FY 2026 net income rose 54.3% to $3.4 million, or $0.39 per diluted share
Cash from operations fell to $9.7 million from $11.4 million; the company repurchased $3.9 million of stock
CEO Jim Cunniff expects to retire on or about April 2, 2027 and will leave the board upon retirement
Electromed reported results for the quarter ended March 31, 2026, with net revenues of $18.6 million, up 18.4% from $15.7 million a year earlier, and net income of $3.0 million, or $0.35 per diluted share, up 58.8%. The company also said it updated its investor presentation for meetings with investors and analysts.
Net revenues of $18.6 million, up 18.4% from $15.7 million in the third quarter of fiscal 2025.
Net income of $3.0 million, or $0.35 per diluted share, versus $1.9 million, or $0.21 per diluted share, a year earlier.
Operating income of $3.8 million, or 20.3% of net revenues, up 76.0% from $2.1 million.
As of March 31, 2026, cash was $17.0 million with no debt; nine-month share repurchases totaled $3.9 million.
Electromed reported results for the quarter ended December 31, 2025. Net revenues rose 16.3% year over year to $18.9 million, and net income rose 40.3% to $2.8 million, or $0.32 per diluted share, compared with $0.22 a year earlier. The results show revenue and profit both improving, and the company also reported $2.8 million in share repurchases during the quarter.
Net revenues were $18.9 million, up 16.3% from $16.3 million in the prior-year quarter
Operating income was $3.6 million, up 42.4%, with an operating margin of 19.2% of net revenues
Net income was $2.8 million, or $0.32 per diluted share, versus $2.0 million, or $0.22 per diluted share
As of December 31, 2025, the company had $13.8 million in cash and no debt, after repurchasing $2.8 million of common stock in the quarter
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.
Only material 8-Ks get a brief: results, deals, executive changes, restructuring, impairments, delisting notices, restatements, cybersecurity incidents and other disclosed events. Routine filings (vote results, exhibits only) are skipped. Every Electromed, Inc. filing is on SEC EDGAR ↗. 8-K briefs of other companies →